Teleflex Incorporated $TFX Shares Sold by Walleye Capital LLC

Walleye Capital LLC lessened its position in shares of Teleflex Incorporated (NYSE:TFX) by 89.4% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 33,758 shares of the medical technology company’s stock after selling 285,410 shares during the period. Walleye Capital LLC’s holdings in Teleflex were worth $4,038,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in TFX. PNC Financial Services Group Inc. raised its position in Teleflex by 11.3% during the first quarter. PNC Financial Services Group Inc. now owns 17,346 shares of the medical technology company’s stock worth $2,075,000 after acquiring an additional 1,759 shares during the last quarter. Heartland Advisors Inc. grew its position in shares of Teleflex by 107.8% in the first quarter. Heartland Advisors Inc. now owns 215,998 shares of the medical technology company’s stock valued at $25,836,000 after purchasing an additional 112,071 shares during the last quarter. Bessemer Group Inc. grew its position in shares of Teleflex by 30.5% in the first quarter. Bessemer Group Inc. now owns 47,798 shares of the medical technology company’s stock valued at $5,718,000 after purchasing an additional 11,180 shares during the last quarter. Illinois Municipal Retirement Fund increased its stake in shares of Teleflex by 17.1% during the 1st quarter. Illinois Municipal Retirement Fund now owns 24,596 shares of the medical technology company’s stock worth $2,942,000 after purchasing an additional 3,591 shares in the last quarter. Finally, Principal Financial Group Inc. increased its stake in shares of Teleflex by 2.0% during the 1st quarter. Principal Financial Group Inc. now owns 214,193 shares of the medical technology company’s stock worth $25,620,000 after purchasing an additional 4,214 shares in the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Trading Up 0.2%

NYSE TFX opened at $135.24 on Thursday. The company has a market cap of $5.99 billion, a P/E ratio of -5.93, a P/E/G ratio of 1.00 and a beta of 0.82. Teleflex Incorporated has a 12 month low of $100.18 and a 12 month high of $139.67. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The company has a 50-day moving average of $130.79 and a 200-day moving average of $120.74.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business had revenue of $548.30 million for the quarter, compared to analysts’ expectations of $536.91 million. During the same period last year, the company earned $1.44 earnings per share. The company’s quarterly revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities analysts predict that Teleflex Incorporated will post 6.7 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s payout ratio is currently -5.96%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and upped their target price for the company from $135.00 to $155.00 in a research note on Friday, May 8th. Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $140.00 to $160.00 in a research report on Monday, June 8th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Wednesday, June 24th. Raymond James Financial restated an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Finally, Wells Fargo & Company increased their price objective on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $148.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.